Comprehensive analysis of clinicopathologic features and p53 mutation in neuroendocrine neoplasms of the breast: experience from a large academic center

Tavassoli F, Schnitt S, Hoefler H (2003) Intraductal proliferative lesions. In: Tavassoli F, Devilee P (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC press, Lyon

Google Scholar 

Feyrter F (1963) On the carcinoid growth form of the carcinoma mammae, especially the carcinoma solidum (gelatinosum) mammae (in German). Frankf Z Pathol 73:24–39

CAS  PubMed  Google Scholar 

Miremadi A, Pinder S, Lee A et al (2002) Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology 40(3):215–222

Article  CAS  PubMed  Google Scholar 

Gallo M, Campione S, Di Vito V et al (2021) Primary neuroendocrine neoplasms of the breast: still open issues. Front Endocrinol. https://doi.org/10.3389/fendo.2020.610230

Article  Google Scholar 

Tan PH, Ellis I, Allison K et al (2020) The 2019 World Health Organization classification of tumours of the breast. Histopathology. https://doi.org/10.1111/his.14091

Article  PubMed  PubMed Central  Google Scholar 

Rindi G, Klimstra DS, Abedi-Ardekani B et al (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31(12):1770–1786

Article  PubMed  PubMed Central  Google Scholar 

Pareja F, D’Alfonso TM (2020) Neuroendocrine neoplasms of the breast: a review focused on the updated World Health Organization (WHO) morphologic classification. Breast J 26(6):1160–1167

Article  PubMed  Google Scholar 

Yang L, Roy M, Lin H et al (2021) Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast. Breast Cancer Res Treat 186(2):403–415

Article  PubMed  Google Scholar 

Biganzoli E, Coradini D, Ambrogi F et al (2011) p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features. Jpn J Clin Oncol 41(2):172–179

Article  PubMed  Google Scholar 

Bean GR, Najjar S, Shin SJ et al (2022) Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast. Mod Pathol 35(10):1349–1361

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Wei B, Albarracin CT, Hu J, Abraham SC, Wu Y (2014) Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database. BMC Cancer 14:147

Article  PubMed  PubMed Central  Google Scholar 

Rovera F, Masciocchi P, Coglitore A et al (2008) Neuroendocrine carcinomas of the breast. Int J Surg 6:S113–S115

Article  PubMed  Google Scholar 

Lavigne M, Menet E, Tille J-C et al (2018) Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast. Mod Pathol 31(1):68–82

Article  CAS  PubMed  Google Scholar 

Tian Z, Wei B, Tang F et al (2011) Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol 42(8):1169–1177

Article  CAS  PubMed  Google Scholar 

Zekioglu O, Ylz Erhan, Çiriş M, Bayramoglu H (2003) Neuroendocrine differentiated carcinomas of the breast: a distinct entity. Breast. 12(4):251–257

Article  PubMed  Google Scholar 

Lopez-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernado L, Menendez JA (2008) Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling. Oncol Rep 20(6):1369–1374

PubMed  Google Scholar 

Lavigne M, Menet E, Tille J-C et al (2018) Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast. Mod Pathol 31(1):68–82

Article  CAS  PubMed  Google Scholar 

Koboldt D, Fulton R, McLellan M et al (2012) Comprehensive molecular portraits of human breast tumours. Nature 490(7418):61–70

Article  CAS  Google Scholar 

Li J-p, Zhang X-m, Zhang Z, Zheng L-h, Jindal S, Liu Y-j (2019) Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma. Medicine. https://doi.org/10.1097/MD.0000000000015449

Article  PubMed  PubMed Central  Google Scholar 

Gasco M, Shami S, Crook T (2002) The p53 pathway in breast cancer. Breast Cancer Res 4(2):1–7

Article  Google Scholar 

Ang D, Ballard M, Beadling C et al (2015) Novel mutations in neuroendocrine carcinoma of the breast: possible therapeutic targets. Appl Immunohistochem Mol Morphol 23(2):97–103

Article  CAS  PubMed  Google Scholar 

Marchiò C, Geyer FC, Ng CK et al (2017) The genetic landscape of breast carcinomas with neuroendocrine differentiation. J Pathol 241(3):405–419

Article  PubMed  Google Scholar 

Wei B, Ding T, Xing Y et al (2010) Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer 116(19):4463–4473

Article  PubMed  Google Scholar 

Wei Y, Ke X, Yu J et al (2022) Clinical and genomic analyses of neuroendocrine neoplasms of the breast. Mod Pathol 35(4):495–505

Article  CAS  PubMed  Google Scholar 

Lakhani SR, Ellis IO, Schnitt S, Tan PH, van de Vijver M (2012) WHO classification of tumours of the breast. International Agency for Research on Cancer, Lyon

Google Scholar 

Tang F, Wei B, Tian Z et al (2011) Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology 59(1):106–115

Article  PubMed  Google Scholar 

Makuuchi R, Terashima M, Kusuhara M et al (2017) Comprehensive analysis of gene mutation and expression profiles in neuroendocrine carcinomas of the stomach. Biomed Res 38(1):19–27

Article  CAS  PubMed  Google Scholar 

Pizzi S, Azzoni C, Bassi D, Bottarelli L, Milione M, Bordi C (2003) Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract. Cancer Interdiscip Intern J Am Cancer Soc 98(6):1273–1282

CAS  Google Scholar 

Furlan D, Cerutti R, Uccella S et al (2004) Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract. Clin Cancer Res 10(3):947–957

Article  CAS  PubMed  Google Scholar 

Sahnane N, Furlan D, Monti M et al (2015) Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity. Endocr Relat Cancer 22(1):35–45

Article  CAS  PubMed  Google Scholar 

Chan AO-O, Kim SG, Bedeir A, Issa J-P, Hamilton SR, Rashid A (2003) CpG island methylation in carcinoid and pancreatic endocrine tumors. Oncogene 22(6):924–934

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif